NeuroVoices
Every Wednesday, NeurologyLive®'s NeuroVoices series features in-depth, exclusive conversations with a wide variety of experts in the care and management of patients with neurologic diseases about a range of topics in clinical care and therapeutic development.
NeuroVoices: Jiwon Oh, MD, PhD, on Radiologically Isolated Syndrome as a Precursor to MS
March 9th 2022The staff neurologist and medical director of the Barlo Multiple Sclerosis Program at St Michaels Hospital provided insight on the use of biomarkers to improve management of RIS and uncover more as it relates to MS.
NeuroVoices: Imad Najm, MD, on Aiming to Prevent Neurological Disorders Before Symptom Onset
February 9th 2022The director of Cleveland Clinic’s Epilepsy Center discussed the new Cleveland Clinic Brain Study, which will evaluate predisease fingerprints from patients who go on to develop neurological disorders.
NeuroVoices: Joanna Hellmuth, MD, MS, on COVID-19 Pathogenesis and Long-Term Cognitive Changes
February 2nd 2022The cognitive neurologist at the University of California, San Francisco provided insight on the research needed to explain more about COVID-19’s pathogenesis and the realistic possibility of developing neurocognitive disorders.
NeuroVoices: Joanna Hellmuth, MD, MS, on Recognizing, Characterizing Post-COVID Cognitive Changes
January 26th 2022The cognitive neurologist at the University of California, San Francisco discussed recently published data on the presence of cognitive post-acute sequelae of COVID-19 and the need to legitimize these conditions.
NeuroVoices: Irene Wang, PhD, on the Clinical Utility of MR Fingerprinting in Epilepsy
January 12th 2022The research director and staff scientist at Cleveland Clinic’s Epilepsy Center discussed why MR fingerprinting holds significant clinical potential in epilepsy and epilepsy-related disorders.
NeuroVoices: Anne-Maree Kelly, MD, on Evaluating and Improving Care for Migraine in the ED
December 29th 2021The director of the Joseph Epstein Center for Emergency Medicine Research provided context on a study that showed wide variation in EDs diagnosis, treatment, and management of headache.
NeuroVoices: Jessica Fesler, MD, MEd, on the Need to Improve and Integrate Seizure Tracking Apps
December 8th 2021The staff epileptologist at Cleveland Clinic’s Epilepsy Center discussed the current state of seizure tracking applications, their limitations, and their untapped potential to be integrated in clinical care and with electronic medical records.
NeuroVoices: Orrin Devinsky, MD, on Unanswered Questions With SUDEP, Heart Rate Variability
November 24th 2021The director of the Comprehensive Epilepsy Center at NYU Langone discussed the large-scale impact heart rate variability has on preventing SUDEP and the unanswered questions that remain.
NeuroVoices: Alexander Merkler, MD, MS, on Anticoagulants for Stroke and Ventricular Dysfunction
November 10th 2021The assistant professor of neurology at Weill Cornell Medicine provided thoughts on his exploratory analysis, which found rivaroxaban to be superior to aspirin in reducing recurrent stroke.
NeuroVoices: Le Hua, MD, on Siponimod’s Efficacy Regardless of Age
November 3rd 2021The director of the Multiple Sclerosis Program at Cleveland Clinic’s Lou Ruvo Center for Brain Health provided context on the EXPAND study, which evaluated treatment efficacy and safety in older and younger patients on siponimod (Mayzent; Novartis).
NeuroVoices: Ilya Kister, MD, on Understanding Long-Term Responses to Vaccines in MS
October 27th 2021The professor of neurology at the NYU Grossman School of Medicine provided his thoughts on the VIOLA study and the importance of monitoring cell response of post-vaccinated patients with MS on DMTs.
NeuroVoices: David R. Lynch, MD, PhD, on the First Potentially Approved Friedreich Ataxia Treatment
September 29th 2021The professor of neurology at the University of Pennsylvania Perelman School of Medicine discussed the state of care for Friedrich ataxia and omaveloxolone’s potential to become its first approved therapy.
NeuroVoices: Paul G. Mathew, MD, on Educating Clinical Community on Nerve Block Surgery Benefits
September 8th 2021The assistant professor of neurology at Harvard Medical School provided insight on how to improve care for posttraumatic headache, as well as limitations and benefits to nerve block surgeries.
NeuroVoices: Shazam Hussain, MD, FRCP, FAHA, on Ultra-Early IV tPA to Treat Emergent LVO
August 25th 2021The director of the Cerebrovascular Center at Cleveland Clinic provided context on why stroke systems should incorporate IV tPA as early as possible to treat emergent large vessel occlusion.
NeuroVoices: James Galvin, MD, MPH, on Location and Greenhouse Space Effects on Alzheimer Risk
August 18th 2021The director of the Comprehensive Center for Brain Health at the University of Miami Miller School of Medicine provided context on greenhouse spaces and their preventive benefits in Alzheimer disease.
NeuroVoices: Jacobo Mintzer, MD, MPA, on Methylphenidate’s Impact on Alzheimer Apathy
August 11th 2021The professor of health science at the Medical University of South Carolina discussed robust results from the phase 3 ADMET 2 study evaluating methylphenidate to treat apathy in Alzheimer disease.
